MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7

Breast Cancer Research

Volumn 14, Issue 1, 2012, Pages

  Kim, Seok Jun ^a,c   Shin, Ji Young ^a   Lee, Kang Duck ^a   Bae, Young Ki ^a   Sung, Ki W ^b   Nam, Seok J ^b   Chun, Kyung Hee ^c  

^a National Cancer Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; MICRORNA; MICRORNA LET 7A; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; CCL21 PROTEIN, HUMAN; CCR7 PROTEIN, HUMAN; MIRNLET7 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; NONHUMAN; ZEBRA FISH; ANIMAL; BREAST TUMOR; CANCER INVASION; CANCER TRANSPLANTATION; CELL MOTION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PAGET NIPPLE DISEASE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL21; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RECEPTORS, CCR7; RNA INTERFERENCE; ZEBRAFISH;

EID: 84862806941     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3098     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007, 608:1-22. 10.1007/978-0-387-74039-3_1, 17993229.
3. Beauvillain C, Cunin P, Doni A, Scotet M, Jaillon S, Loiry ML, Magistrelli G, Masternak K, Chevailler A, Delneste Y, et al. CCR7 is involved in the migration of neutrophils to lymph nodes. Blood 2011, (117):1196-204.
4. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 2008, 25:345-56. 10.1007/s10585-007-9097-3, 17891505.
5. Cunningham HD, Shannon LA, Calloway PA, Fassold BC, Dunwiddie I, Vielhauer G, Zhang M, Vines CM. Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Transl Oncol 2010, 3:354-61. 3000460, 21151474.
6. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 2006, 25:357-71. 10.1007/s10555-006-9003-5, 17016763.
7. Weninger W, von Andrian UH. Chemokine regulation of naive T cell traffic in health and disease. Semin Immunol 2003, 15:257-70. 10.1016/j.smim.2003.08.007, 15001175.
8. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004, 10:2351-8. 10.1158/1078-0432.CCR-03-0195, 15073111.
9. Shields JD, Emmett MS, Dunn DB, Joory KD, Sage LM, Rigby H, Mortimer PS, Orlando A, Levick JR, Bates DO. Chemokine-mediated migration of melanoma cells towards lymphatics: a mechanism contributing to metastasis. Oncogene 2007, 26:2997-3005. 10.1038/sj.onc.1210114, 17130836.
10. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-6. 10.1038/35002607, 10706289.
11. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-47. 10.1016/j.cell.2005.01.014, 15766527.
12. Qian ZR, Asa SL, Siomi H, Siomi MC, Yoshimoto K, Yamada S, Wang EL, Rahman MM, Inoue H, Itakura M, Kudo E, Sano T. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol 2009, 22:431-41. 10.1038/modpathol.2008.202, 19136928.
13. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007, 21:1025-30. 10.1101/gad.1540407, 1855228, 17437991.
14. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006, 29:903-6. 10.1248/bpb.29.903, 16651716.
15. Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010, 29:937-48. 10.1038/onc.2009.406, 19935707.
16. Zhu YM, Zhong ZX, Liu ZM. Relationship between let-7a and gastric mucosa cancerization and its significance. World J Gastroenterol 2010, 16:3325-9. 10.3748/wjg.v16.i26.3325, 2900726, 20614490.
17. Long XB, Sun GB, Hu S, Liang GT, Wang N, Zhang XH, Cao PP, Zhen HT, Cui YH, Liu Z. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009, 22:1189-95.
18. Kim SJ, Choi IJ, Cheong TC, Lee SJ, Lotan R, Park SH, Chun KH. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 2010, 138:1035-45. e1031-2, 10.1053/j.gastro.2009.09.061, 19818782.
19. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-70. 10.1158/0008-5472.CAN-05-1783, 16103053.
20. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-23. 10.1016/j.cell.2007.10.054, 18083101.
21. Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010, 29:937-48. 10.1038/onc.2009.406, 19935707.
22. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010, 9:775-89. 10.1038/nrd3179, 20885409.
23. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-6. 10.1016/S0092-8674(01)00616-X, 11779458.
24. Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG. microRNA, cell cycle, and human breast cancer. Am J Pathol 2010, 176:1058-64. 10.2353/ajpath.2010.090664, 2832125, 20075198.
25. Cowland JB, Hother C, Gronbaek K. MicroRNAs and cancer. APMIS 2007, 115:1090-106. 10.1111/j.1600-0463.2007.apm_775.xml.x, 18042145.
26. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12. 10.1016/j.ydbio.2006.08.028, 16989803.
27. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-4. 10.1126/science.1065329, 11679672.